Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
-
Catheter Cardiovasc Interv · Aug 2013
Case ReportsAortic aneurysm 18 month after transfemoral implantation of a self-expandable aortic valve prosthesis.
We report a case of a new developed aortic aneurysm 18 month after transcatheter aortic valve implantation in an 80-year-old woman. The abnormality was an incidental finding during routine coronary angiography.
-
Catheter Cardiovasc Interv · Aug 2013
Review Meta AnalysisGlycoprotein IIb/IIIa inhibitors with or without thienopyridine pretreatment improve outcomes after primary percutaneous coronary intervention in high-risk patients with ST elevation myocardial infarction--a meta-regression of randomized controlled trials.
Recent studies have casted a doubt on usefulness of routine glycoprotein IIb/IIIA inhibitors (GPI) in patients, pretreated with aspirin and clopidogrel, undergoing primary percutaneous coronary intervention (PCI) for ST elevation myocardial infarction (STEMI). ⋯ The benefit from GPI use in primary PCI for STEMI appears to depend on mortality risk, and not on thienopyridine pretreatment.
-
Catheter Cardiovasc Interv · Aug 2013
Randomized Controlled TrialPatient preferences for coronary artery bypass graft surgery or percutaneous intervention in multivessel coronary artery disease.
Determine if patients prefer multivessel percutaneous coronary intervention (mv-PCI) over coronary artery bypass graft surgery (CABG) for treatment of symptomatic multivessel coronary artery disease (mv-CAD) despite high 1-year risk. ⋯ Patients favor mv-PCI over CABG to treat mv-CAD, even if 1-year risks of death and repeat procedures far exceed risk with CABG. Physicians are more influenced by actual risk and prefer mv-PCI less than patients despite similarly quoted 1-year risks.
-
Catheter Cardiovasc Interv · Aug 2013
Multicenter StudyHybrid endovascular repair for aortic arch pathology: intermediate outcomes and complications: a retrospective analysis.
To evaluate the outcomes of hybrid endovascular repair for aortic arch pathology. ⋯ Hybrid treatment with supra-aortic vessel transposition and endovascular repair may be an option in frail patients in who open procedures is too risky.